Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors

Katsuto Takenaka, H. Gondo, K. Tanimoto, K. Nagafuji, T. Fujisaki, Shinichi Mizuno, Toshihiro Miyamoto, T. Okamura, S. Hayashi, T. Eto, K. Osaki, K. Yamasaki, T. Shibuya, N. Harada, T. Teshima, E. Matsuishi, T. Minematsu, Y. Minamishima, M. Harada, Y. Niho

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Cytomegalovirus (CMV) infection and CMV-associated disease were monitored using the CMV antigenemia assay in 72 patients who received allogenic bone marrow transplantation (BMT), and their incidences were compared between related and unrelated donor transplant patients. The incidence of CMV infection after BMT was significantly higher in patients who received transplants from HLA-matched unrelated donors than from HLA-matched sibling donors (87% vs 53%, P < 0.05). CMV-associated disease developed in 73% of unrelated and 14% of sibling donor transplant patients (P < 0.01). The peak levels of CMV antigenemia were significantly higher in unrelated donors than in sibling donor transplant patients (16 vs 1 CMV antigen-positive cells per 50 000 WBCs, P < 0.01). The median number of CMV antigen-positive cells on first detection was also significantly higher in unrelated donor transplant patients (15 vs 1, P < 0.01). The detection of CMV antigen-positive cells preceded the development of CMV-associated disease in 18% of unrelated donor transplant patients, suggesting a lower predictive value of CMV antigenemia for subsequent CMV-associated disease in unrelated donor BMT. Careful monitoring and further studies are needed for the early diagnosis and prevention of CMV-associated disease in unrelated donor BMT.

Original languageEnglish
Pages (from-to)241-248
Number of pages8
JournalBone Marrow Transplantation
Volume19
Issue number3
DOIs
Publication statusPublished - Feb 1 1997

Fingerprint

Unrelated Donors
Homologous Transplantation
Cytomegalovirus Infections
Cytomegalovirus
Bone Marrow Transplantation
Incidence
Transplants
Siblings
Tissue Donors
Antigens
Early Diagnosis

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. / Takenaka, Katsuto; Gondo, H.; Tanimoto, K.; Nagafuji, K.; Fujisaki, T.; Mizuno, Shinichi; Miyamoto, Toshihiro; Okamura, T.; Hayashi, S.; Eto, T.; Osaki, K.; Yamasaki, K.; Shibuya, T.; Harada, N.; Teshima, T.; Matsuishi, E.; Minematsu, T.; Minamishima, Y.; Harada, M.; Niho, Y.

In: Bone Marrow Transplantation, Vol. 19, No. 3, 01.02.1997, p. 241-248.

Research output: Contribution to journalArticle

Takenaka, K, Gondo, H, Tanimoto, K, Nagafuji, K, Fujisaki, T, Mizuno, S, Miyamoto, T, Okamura, T, Hayashi, S, Eto, T, Osaki, K, Yamasaki, K, Shibuya, T, Harada, N, Teshima, T, Matsuishi, E, Minematsu, T, Minamishima, Y, Harada, M & Niho, Y 1997, 'Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors', Bone Marrow Transplantation, vol. 19, no. 3, pp. 241-248. https://doi.org/10.1038/sj.bmt.1700637
Takenaka, Katsuto ; Gondo, H. ; Tanimoto, K. ; Nagafuji, K. ; Fujisaki, T. ; Mizuno, Shinichi ; Miyamoto, Toshihiro ; Okamura, T. ; Hayashi, S. ; Eto, T. ; Osaki, K. ; Yamasaki, K. ; Shibuya, T. ; Harada, N. ; Teshima, T. ; Matsuishi, E. ; Minematsu, T. ; Minamishima, Y. ; Harada, M. ; Niho, Y. / Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. In: Bone Marrow Transplantation. 1997 ; Vol. 19, No. 3. pp. 241-248.
@article{a992079580c547fa87074ab4ac3e2f9a,
title = "Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors",
abstract = "Cytomegalovirus (CMV) infection and CMV-associated disease were monitored using the CMV antigenemia assay in 72 patients who received allogenic bone marrow transplantation (BMT), and their incidences were compared between related and unrelated donor transplant patients. The incidence of CMV infection after BMT was significantly higher in patients who received transplants from HLA-matched unrelated donors than from HLA-matched sibling donors (87{\%} vs 53{\%}, P < 0.05). CMV-associated disease developed in 73{\%} of unrelated and 14{\%} of sibling donor transplant patients (P < 0.01). The peak levels of CMV antigenemia were significantly higher in unrelated donors than in sibling donor transplant patients (16 vs 1 CMV antigen-positive cells per 50 000 WBCs, P < 0.01). The median number of CMV antigen-positive cells on first detection was also significantly higher in unrelated donor transplant patients (15 vs 1, P < 0.01). The detection of CMV antigen-positive cells preceded the development of CMV-associated disease in 18{\%} of unrelated donor transplant patients, suggesting a lower predictive value of CMV antigenemia for subsequent CMV-associated disease in unrelated donor BMT. Careful monitoring and further studies are needed for the early diagnosis and prevention of CMV-associated disease in unrelated donor BMT.",
author = "Katsuto Takenaka and H. Gondo and K. Tanimoto and K. Nagafuji and T. Fujisaki and Shinichi Mizuno and Toshihiro Miyamoto and T. Okamura and S. Hayashi and T. Eto and K. Osaki and K. Yamasaki and T. Shibuya and N. Harada and T. Teshima and E. Matsuishi and T. Minematsu and Y. Minamishima and M. Harada and Y. Niho",
year = "1997",
month = "2",
day = "1",
doi = "10.1038/sj.bmt.1700637",
language = "English",
volume = "19",
pages = "241--248",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors

AU - Takenaka, Katsuto

AU - Gondo, H.

AU - Tanimoto, K.

AU - Nagafuji, K.

AU - Fujisaki, T.

AU - Mizuno, Shinichi

AU - Miyamoto, Toshihiro

AU - Okamura, T.

AU - Hayashi, S.

AU - Eto, T.

AU - Osaki, K.

AU - Yamasaki, K.

AU - Shibuya, T.

AU - Harada, N.

AU - Teshima, T.

AU - Matsuishi, E.

AU - Minematsu, T.

AU - Minamishima, Y.

AU - Harada, M.

AU - Niho, Y.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Cytomegalovirus (CMV) infection and CMV-associated disease were monitored using the CMV antigenemia assay in 72 patients who received allogenic bone marrow transplantation (BMT), and their incidences were compared between related and unrelated donor transplant patients. The incidence of CMV infection after BMT was significantly higher in patients who received transplants from HLA-matched unrelated donors than from HLA-matched sibling donors (87% vs 53%, P < 0.05). CMV-associated disease developed in 73% of unrelated and 14% of sibling donor transplant patients (P < 0.01). The peak levels of CMV antigenemia were significantly higher in unrelated donors than in sibling donor transplant patients (16 vs 1 CMV antigen-positive cells per 50 000 WBCs, P < 0.01). The median number of CMV antigen-positive cells on first detection was also significantly higher in unrelated donor transplant patients (15 vs 1, P < 0.01). The detection of CMV antigen-positive cells preceded the development of CMV-associated disease in 18% of unrelated donor transplant patients, suggesting a lower predictive value of CMV antigenemia for subsequent CMV-associated disease in unrelated donor BMT. Careful monitoring and further studies are needed for the early diagnosis and prevention of CMV-associated disease in unrelated donor BMT.

AB - Cytomegalovirus (CMV) infection and CMV-associated disease were monitored using the CMV antigenemia assay in 72 patients who received allogenic bone marrow transplantation (BMT), and their incidences were compared between related and unrelated donor transplant patients. The incidence of CMV infection after BMT was significantly higher in patients who received transplants from HLA-matched unrelated donors than from HLA-matched sibling donors (87% vs 53%, P < 0.05). CMV-associated disease developed in 73% of unrelated and 14% of sibling donor transplant patients (P < 0.01). The peak levels of CMV antigenemia were significantly higher in unrelated donors than in sibling donor transplant patients (16 vs 1 CMV antigen-positive cells per 50 000 WBCs, P < 0.01). The median number of CMV antigen-positive cells on first detection was also significantly higher in unrelated donor transplant patients (15 vs 1, P < 0.01). The detection of CMV antigen-positive cells preceded the development of CMV-associated disease in 18% of unrelated donor transplant patients, suggesting a lower predictive value of CMV antigenemia for subsequent CMV-associated disease in unrelated donor BMT. Careful monitoring and further studies are needed for the early diagnosis and prevention of CMV-associated disease in unrelated donor BMT.

UR - http://www.scopus.com/inward/record.url?scp=0031054161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031054161&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1700637

DO - 10.1038/sj.bmt.1700637

M3 - Article

C2 - 9028553

AN - SCOPUS:0031054161

VL - 19

SP - 241

EP - 248

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -